Quality of life in patients with relapsing multiple sclerosis taking intramuscular interferon beta-1a (Avonex®)

被引：0
作者：
Hyde, R.
Rudick, R. A.
Foulds, P.
You, X.
机构：
[1] Biogen Idec Int, Zug, Switzerland
[2] Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH USA
[3] Biogen Idec Inc, Cambridge, MA 02142 USA
来源：
JOURNAL OF NEUROLOGY | 2008年 / 255卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P455
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
[21]   A study of the effect of gender on interferon beta-1a (Avonex® 30 mcg) treatment in patients with multiple sclerosis [J].
Munschauer, FE ;
Herndon, R ;
Sandrock, AW ;
Tsao, E ;
Berkhoff, JE ;
Stubbendick, A .
MULTIPLE SCLEROSIS, 2005, 11 :S78-S78
[22]   Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis [J].
Rudick, RA ;
Goodkin, DE ;
Jacobs, LD ;
Cookfair, DL ;
Herndon, RM ;
Richert, JR ;
Salazar, AM ;
Fischer, JS ;
Granger, CV ;
Simon, JH ;
Alam, JJ ;
Simonian, NA ;
Campion, MK ;
Bartoszak, DM ;
Bourdette, DN ;
Braiman, J ;
Brownscheidle, CM ;
Coats, ME ;
Cohan, SL ;
Dougherty, DS ;
Kinkel, RP ;
Mass, MK ;
Munschauer, FE ;
Priore, RL ;
Pullicino, PM ;
Scherokman, BJ ;
WeistockGuttman, B ;
Whitham, RH .
NEUROLOGY, 1997, 49 (02) :358-363
[23]   Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis [J].
Vazquez Gomez, Lazaro Aurelio ;
Hidalgo Mesa, Carlos ;
Broche Perez, Yunier ;
Valdes Morales, Yanet .
MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2022, 20 (05) :825-833
[24]   Combination therapy of interferon beta-1a with alefacept for active relapsing multiple sclerosis patients [J].
Weinstock-Guttman, B ;
Ramanathan, M ;
Zivadinov, R ;
Munschauer, FE .
MULTIPLE SCLEROSIS, 2005, 11 :S79-S79
[25]   Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis [J].
Rudick, RA ;
Goodkin, DE ;
Jacobs, LD ;
Cookfair, DL ;
Herndon, RM ;
Richert, JR ;
Salazar, AM ;
Fischer, JS ;
Granger, CV ;
Simon, JH ;
Alam, JJ ;
Simonian, NA ;
Campion, MK ;
Bartoszak, DM ;
Bourdette, DN ;
Braiman, J ;
Brownscheidle, CM ;
Coats, ME ;
Cohan, SL ;
Dougherty, DS ;
Kinkel, RP ;
Mass, MK ;
Munschauer, FE ;
Priore, RL ;
Pullicino, PM ;
Scherokman, BJ ;
Weistock-Guttman, B ;
Whitham, RH .
NEUROLOGY, 2001, 57 (12) :S25-S30
[26]   Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis [J].
Kappos, L. ;
Wiendl, H. ;
Selmaj, K. ;
Arnold, D. L. ;
Havrdova, E. ;
Boyko, A. ;
Kaufman, M. ;
Rose, J. ;
Greenberg, S. ;
Sweetser, M. ;
Riester, K. ;
O'Neill, G. ;
Elkins, J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (15) :1418-1428
[27]   ESTIMATING NET HEALTH BENEFITS OF INTRAMUSCULAR INTERFERON BETA-1A AND FINGOLIMOD IN TREATING PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS [J].
Szabo, S. M. ;
Dembek, C. ;
Moore, P. ;
White, L. A. ;
Wijaya, H. ;
Levy, A. R. .
VALUE IN HEALTH, 2011, 14 (07) :A317-A317
[28]   Estimating Net Health Benefits of Intramuscular Interferon Beta-1a and Fingolimod in Treating Patients with Relapsing-Remitting Multiple Sclerosis [J].
Szabo, Shelagh ;
Dembek, Carole ;
Moore, Peter ;
White, Leigh Ann ;
Wijaya, Hardy ;
Levy, Adrian .
NEUROLOGY, 2012, 78
[29]   Comparing efficacy and side effects of a weekly intramuscular biogeneric/biosimilar interferon beta-1a with Avonex in relapsing remitting multiple sclerosis: A double blind randomized clinical trial [J].
Nafissi, Shahriar ;
Azimi, Amirreza ;
Amini-Harandi, Ali ;
Salami, Shiva ;
Shahkarami, Mohammad Amir ;
Heshmat, Ramin .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2012, 114 (07) :986-989
[30]   Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis (vol 39, pg 285, 1996) [J].
Jacobs, LD .
ANNALS OF NEUROLOGY, 1996, 40 (03) :480-480
12345